Metraipolis › archive › dc_676cc32fc713

Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease — Europe PMC PMID:40831567

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40831567
DOI
10.3389/fimmu.2025.1637159
License (as archived)
solo-consultazione
Archived
2026-10-08T06:22:26.262Z
SHA-256 of the archived text
76ef3b96ca5bc220d2c9e7ba3c3f0a17bd856475408c4be9852d834a8db09095
Stable URL of this page
https://metraipolis.com/documento/dc_676cc32fc713

How to cite

Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease — Europe PMC PMID:40831567 — Europe PMC (en), https://europepmc.org/article/MED/40831567 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_676cc32fc713 (Metraipolis archive dc_676cc32fc713, sha256 76ef3b96ca5bc220d2c9e7ba3c3f0a17bd856475408c4be9852d834a8db09095)
BibTeX
@misc{dc676cc32fc713,
  title = {Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease — Europe PMC PMID:40831567},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40831567},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_676cc32fc713; sha256 76ef3b96ca5bc220d2c9e7ba3c3f0a17bd856475408c4be9852d834a8db09095},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40831567. Agents can read the archived copy with the MCP tool read_document.